- Home
- PRME
PRME
Prime Medicine Inc.
as 03-28-2025 4:00pm EST
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | N/A | IPO Year: | 2022 |
| Target Price: | $13.25 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.65 - $8.27 | Next Earning Date: | 05-09-2025 |
| Revenue: | $2,983,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 126.72% | Revenue Growth (next year): | 422.22% |
Latest Prime Medicine Inc. News
PRME Breaking Stock News: Dive into PRME Ticker-Specific Updates for Smart Investing
Motley Fool
11 days ago
Why Prime Medicine Stock Was Climbing Higher This Week
MT Newswires
11 days ago
Chardan Raises Price Target on Prime Medicine to $16 From $15, Keeps Buy Rating
Motley Fool
12 days ago
Why Prime Medicine Stock Is Soaring Today
BioPharma Dive
13 days ago
Prime sets sights on liver, lung disease as next target for its gene editing tech
MT Newswires
13 days ago
Prime Medicine Launches Preclinical Program for Liver Treatments
GlobeNewswire
13 days ago
Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
GlobeNewswire
a month ago
Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates
GlobeNewswire
a month ago
Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
Compare PRME vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRME Prime Medicine Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.